
Loading, please wait...

Loading, please wait...

Researchers have achieved a significant milestone in in-sensor vision technology by developing a monolithic memristor array based on 2D Ruddlesden-Popper (RP) hybrid perovskites. This advancement addresses the growing need for energy-efficient artificial intelligence and real-time data processing in medical diagnostics. Specifically, the team synthesized BAMAPbBr (BMPB) single crystals to create an architecture that unifies sensing, memory, and computing functions.
The BMPB crystals demonstrate outstanding memristive performance, including an ultrahigh on/off ratio and a long retention time. Most importantly, the device operates with an ultralow power consumption of approximately 82.8 pW. This level of efficiency is vital for the next generation of implantable sensors and portable diagnostic tools. Furthermore, the 5×5 optoelectronic array functions as a self-powered system under 410 nm illumination, exhibiting high responsivity and detectivity.
This hardware-level integration offers transformative potential for various medical fields. For instance, in ophthalmology, in-sensor vision technology could facilitate the development of advanced retinal prosthetics. These devices would process visual information locally, mimicking the human retina's biological function. Additionally, radiology departments might benefit from ultra-fast imaging sensors that reduce data transmission latency during complex procedures. Therefore, this material-level solution provides a robust foundation for energy-efficient AI and Internet of Medical Things (IoMT) systems.
Notably, the researchers verified the system's capabilities through digital logic circuit design and specialized software verification. While they initially demonstrated solar-tracking and plant growth monitoring, the underlying logic applies to many clinical monitoring tasks. Consequently, these 2D RP perovskites represent a major step toward autonomous, intelligent medical hardware.
In-sensor vision technology refers to systems where the image sensor itself performs data processing and memory tasks. This eliminates the need for separate computing units, thereby reducing energy consumption and data transmission delays.
2D Ruddlesden-Popper (RP) perovskites offer high carrier mobility and excellent light absorption. These properties allow for the creation of ultra-low-power, self-powered sensors that are ideal for wearable and implantable medical technology.
Yes, this technology can lead to more efficient radiology equipment. By processing data at the hardware level, sensors can provide real-time analytical insights with minimal power requirements.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or endorsement of specific technologies. Refer to the latest local and national guidelines for clinical practice.
References
Zhang X et al. Self-Powered Phototriggered Memristor Array with pW-Level Computing for Monolithic in-Sensor Vision. Adv Mater. 2026 Feb 21. doi: 10.1002/adma.202523017. PMID: 41721621.
Liu Y et al. Perovskite-Based Memristor with 50-Fold Switchable Photosensitivity for In-Sensor Computing Neural Network. Nano Energy. 2022;100:107464.
Wang Y et al. 2D Hybrid Perovskite Sensors for Environmental and Healthcare Monitoring. PMC NIH. 2024;8(2):e2300026.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers develop a 2D RP perovskite memristor array that integrates sensing and computing for self-powered, pW-level in-sensor vision technology....
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today